Eastern Biopharmaceuticals Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
1,480
- Stock Symbol
-
688513
- Investments
-
2
- Share Price
-
$5.64
- (As of Friday Closing)
Eastern Biopharmaceuticals General Information
Description
Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.
Contact Information
Website
www.eastonpharma.cnCorporate Office
- Number 8 Ankang Road, Shuangliu District
- Chengdu, Sichuan 611731
- China
Corporate Office
- Number 8 Ankang Road, Shuangliu District
- Chengdu, Sichuan 611731
- China
Eastern Biopharmaceuticals Stock Performance
As of 20-Nov-2026, Eastern Biopharmaceuticals’s stock price is $5.64. Its current market cap is $995M with 176M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.64 | $5.84 | $5.64 - $11.71 | $995M | 176M | 1.99M | $0.23 |
Eastern Biopharmaceuticals Financials Summary
As of 30-Sep-2026, Eastern Biopharmaceuticals has a trailing 12-month revenue of $189M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,133,120 | 1,348,153 | 558,445 | 902,892 |
| Revenue | 188,998 | 185,139 | 188,107 | 157,900 |
| EBITDA | 37,365 | 53,074 | 44,815 | 42,911 |
| Net Income | 39,537 | 39,500 | 33,201 | 32,025 |
| Total Assets | 587,576 | 542,810 | 465,765 | 472,132 |
| Total Debt | 30,570 | 20,959 | 15,621 | 31,527 |
Eastern Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Eastern Biopharmaceuticals Patents
Eastern Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026200809-A1 | Salt form of γ-aminobutyric acid derivative, crystal form thereof and preparation method therefor | Pending | 24-Mar-2025 | ||
| WO-2026124439-A1 | Crystal form of benzothiazole derivative, and preparation method therefor and use thereof | Pending | 10-Dec-2024 | ||
| WO-2026091339-A1 | Chidamide polymorph i and preparation method therefor | Pending | 29-Oct-2024 | ||
| WO-2025252109-A1 | Substituted tetrahydrofuran derivative, and preparation method therefor and use thereof | Pending | 04-Jun-2024 | ||
| WO-2025092695-A1 | New heterocyclic covalent inhibitor of menin, preparation method therefor and pharmaceutical use thereof | Inactive | 31-Oct-2023 |
Eastern Biopharmaceuticals Signals
Eastern Biopharmaceuticals Investments (2)
Eastern Biopharmaceuticals’s most recent deal was a Later Stage VC with KCI BioTech for . The deal was made on 30-Jun-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| KCI BioTech | 30-Jun-2023 | Later Stage VC | Laboratory Services (Healthcare) | ||
| Aubrak Therapeutics | 25-Mar-2022 | Early Stage VC | Drug Discovery |
Eastern Biopharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Eastern Biopharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Eastern Biopharmaceuticals Investment | China |
Eastern Biopharmaceuticals FAQs
-
When was Eastern Biopharmaceuticals founded?
Eastern Biopharmaceuticals was founded in 2009.
-
Where is Eastern Biopharmaceuticals headquartered?
Eastern Biopharmaceuticals is headquartered in Chengdu, China.
-
What is the size of Eastern Biopharmaceuticals?
Eastern Biopharmaceuticals has 1,480 total employees.
-
What industry is Eastern Biopharmaceuticals in?
Eastern Biopharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Eastern Biopharmaceuticals a private or public company?
Eastern Biopharmaceuticals is a Public company.
-
What is Eastern Biopharmaceuticals’s stock symbol?
The ticker symbol for Eastern Biopharmaceuticals is 688513.
-
What is the current stock price of Eastern Biopharmaceuticals?
As of 20-Nov-2026 the stock price of Eastern Biopharmaceuticals is $5.64.
-
What is the current market cap of Eastern Biopharmaceuticals?
The current market capitalization of Eastern Biopharmaceuticals is $995M.
-
What is Eastern Biopharmaceuticals’s current revenue?
The trailing twelve month revenue for Eastern Biopharmaceuticals is $189M.
-
What is Eastern Biopharmaceuticals’s annual earnings per share (EPS)?
Eastern Biopharmaceuticals’s EPS for 12 months was $0.23.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process